[en] PURPOSE: We examined p16, p21 and p53 expression in combination with the presence of human papillomavirus (HPV) DNA as molecular markers to predict survival in patients with stage IV hypopharyngeal squamous cell carcinoma (HSCC). METHODS: Paraffin-embedded tumours from HSCC patients (n = 75) were evaluated for p16, p21 and p53 expression by immunohistochemistry. HPV DNA was detected by GP5+/6+ consensus PCR and subsequent genotyping by E6/E7 type-specific PCR for HPV types 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66 and 68. RESULTS: Among the 61 specimens that tested positive for the beta-globin, HPV typing identified 50 patients with high-risk (hr) HPV types. HPV 16E7 DNA was detected in 74% (37 cases) of these specimens. Twelve patients were found to be infected with multiple HPV types. However, the presence of hrHPV DNA was not found to correlate with the proportion of disease-free patients. The 5-year disease-free survival rate was 73% in p53- tumours versus 48% in p53+ tumours (P = 0.008). CONCLUSION: In our series of patients with stage IV HSCC, the hrHPV+ subgroup had a similar prognosis (in terms of recurrence risk) as the HPV- subgroup. p53 overexpression was associated with a worse prognosis.
Research Center/Unit :
Giga-Cancer - ULiège
Disciplines :
Immunology & infectious disease Oncology
Author, co-author :
Ernoux-Neufcoeur, P.
Arafa, M.
Decaestecker, C.
Duray, A.
Remmelink, M.
Leroy, X.
Herfs, Michael ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Somja, Joan ; Centre Hospitalier Universitaire de Liège - CHU > Anatomie pathologique
Depuydt, C. E.
Delvenne, Philippe ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Anatomie et cytologie pathologiques
Saussez, S.; Laboratory of Anatomy, Faculty of Medicine and Pharmacy, University of Mons, Pentagone 2A–Avenue du Champ de Mars, 6, B-7000 Mons, Belgium
Language :
English
Title :
Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma.
L-M Aaltonen H Rihkanen A Vaheri 2002 Human papillomavirus in larynx The Laryngoscope 112 700 707 10.1097/00005537-200204000-00020 12150527
L Alos S Moyona A Nadal, et al. 2009 Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome Cancer 115 2701 2709 10.1002/cncr.24309 19365846
M Arbyn I Benoy C Simoens, et al. 2009 Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium Cancer Epidemiol Biomarkers Prev 18 321 330 1:CAS:528: DC%2BD1MXhvFCjsA%3D%3D 10.1158/1055-9965.EPI-08-0510 19124515
S Begum ML Gillison MA Ansari-Lari, et al. 2003 Detection for papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin Clin Cancer Res 9 6469 6475 1:CAS:528: DC%2BD3sXhtVSqurvJ 14695150
J Bernier C Domenge M Ozsahin, et al. 2004 Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 1945 1952 1:CAS:528:DC%2BD2cXjslehsrk%3D 10.1056/NEJMoa032641 15128894 (Pubitemid 38580197)
GL Clayman MG Stewart RS Weber, et al. 1994 Human papillomavirus in laryngeal and hypopharyngeal carcinomas. Relationship to survival Arch Otolaryngol Head and Neck Surg 120 743 748 1:STN:280:DyaK2c3ovV2lsw%3D%3D
JS Cooper TF Pajak AA Forastiere, et al. 2004 Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 1937 1944 10.1056/NEJMoa032646 15128893 (Pubitemid 38580196)
G D'Souza AR Kreimer R Viscidi, et al. 2007 Case-control study of human papillomavirus and oropharyngeal cancer N Engl J Med 356 1944 1956 10.1056/NEJMoa065497 17494927 (Pubitemid 46740304)
H Dahlstrand A Näsman M Romanitan, et al. 2008 Human papillomavirus accounts both for increased incidence and better prognosis in tonsillar cancer Anticancer Res 28 1133 1138 18505048
CE Depuydt IH Benoy EJ Bailleul, et al. 2006 Improved endocervical sampling and HPV viral load detection by Cervex-Brush Combi Cytopathology 17 374 381 1:STN:280:DC%2BD28jjtFCqsQ%3D%3D 10.1111/j.1365-2303.2006.00386.x 17168921 (Pubitemid 44808532)
CE Depuydt GA Boulet CA Horvath, et al. 2007 Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types J Cell Mol Med 11 881 891 1:CAS:528:DC%2BD2sXhtFSks77I 10.1111/j.1582-4934.2007. 00073.x 17760847 (Pubitemid 47313308)
JR Grandis JA Pietenpol JS Greeberger, et al. 2004 Head and neck cancer: meeting summary and research opportunities Cancer Res 64 126 129 10.1158/0008-5472.CAN-04-2445 (Pubitemid 39446952)
BG Hansson K Rosenquist A Antonsson, et al. 2005 Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden Acta Otolaryngol 125 1337 1344 10.1080/00016480510043945 16303684 (Pubitemid 41722001)
E Hara R Smith D Parry, et al. 1996 Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence Mol Cell Biol 16 859 867 1:CAS:528:DyaK28XhtFOmurc%3D 8622687
KD Hunter EK Parkinson PR Harrison 2005 Profiling early head and neck cancer Nat Rev Cancer 5 127 135 1:CAS:528:DC%2BD2MXoslKrsw%3D%3D 10.1038/nrc1549 15685196
Hyams VJ, Batsakis JG, Michaels L (eds) (1988) Tumors of the upper respiratory tract and ear. Atlas of tumor pathology. Armed Forces Institute of Pathology, Washington, DC
B Kumar KG Cordell JS Lee, et al. 2007 Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender and smoking Int J Radiat Oncol Biol Phys 69 109 111
DW Morgan V Abdullah R Quiney, et al. 1991 Human papilloma virus and carcinoma of the laryngopharynx J Laryngol Otol 105 288 290 1:STN:280: DyaK3M3isFGrsA%3D%3D 10.1017/S0022215100115634 1851198
K Munger BA Werness N Dyson, et al. 1989 Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product EMBO J 8 4099 4105 1:STN:280:DyaK3c%2Fns1Wgsw%3D%3D 2556261
IB Paz N Cook T Odom-Maryon, et al. 1997 Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring Cancer 79 595 604 1:STN:280:DyaK2s7otVWqtQ%3D%3D 10.1002/(SICI)1097-0142(19970201)79:3<595::AID-CNCR24>3.0.CO;2-Y 9028373 (Pubitemid 27051787)
A Psyrri D DiMaio 2008 Human papillomavirus and head and neck cancer Nat Clin Pract Oncol 5 24 31 1:CAS:528:DC%2BD1cXhtFGnuw%3D%3D 10.1038/ncponc0984 18097454 (Pubitemid 351512426)
AL Reed J Califano P Cairns, et al. 1996 High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma Cancer Res 56 3630 3633 1:CAS:528:DyaK28XltVKlu7g%3D 8705996
N Reimers HU Kasper SJ Weissenborn, et al. 2007 Combined analysis of HPV-DNA, p16 and EGFR expression to predict prognosis in oropharyngeal cancer Int J Cancer 120 1731 1738 1:CAS:528:DC%2BD2sXjtFOktL0%3D 10.1002/ijc.22355 17236202 (Pubitemid 46399359)
JM Ritchie EM Smith KF Summersgill, et al. 2003 Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx Int J Cancer 104 336 344 1:CAS:528:DC%2BD3sXhvFyks7g%3D 10.1002/ijc.10960 12569557 (Pubitemid 36249816)
K Rosenquist J Wennerberg K Annertz, et al. 2007 Recurrence in patients with oral and oropharyngeal squamous cell carcinoma: human papillomavirus and other risk factors Acta Otolaryngol 127 980 987 10.1080/00016480601110162 17712679 (Pubitemid 47345810)
S Saussez C Decaestecker F Lorfevre, et al. 2008 Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas Histopathology 52 483 493 1:STN:280: DC%2BD1c7lslGgsA%3D%3D 10.1111/j.1365-2559.2008.02973.x 18315601 (Pubitemid 351327984)
Schantz SP, Harrison LB, Forastiere AA (1997) Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, vol 1, 5th edn. JP Lippincott, Philadelphia, pp 741-847
M Scheffner BA Werness JM Huibregtse, et al. 1990 The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1129 1136 1:CAS:528:DyaK3MXls12itg%3D%3D 10.1016/0092-8674(90)90409-8 2175676
EM Smith D Wang LM Rubenstein, et al. 2008 Association between p53 and human papillomavirus in head and neck cancer survival Cancer Epidemiol Biomarkers Prev 17 421 427 1:CAS:528:DC%2BD1cXhslaru7c%3D 10.1158/1055-9965.EPI- 07-2597 18268127 (Pubitemid 351272796)
PM Weinberger Z Yu BG Haffty, et al. 2006 Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis J Clin Oncol 24 736 747 1:CAS:528:DC%2BD28XitVGisLc%3D 10.1200/JCO.2004.00.3335 16401683 (Pubitemid 46622040)
Wittekind C, Greene FL, Hutter RRP et al. (2004) TNM Atlas, 6th Edn. UICC, Berlin
